View Older Stories View More Recent Stories

Jul 2, 2018 11:35AM Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash
Jun 19, 2018 06:18AM Roche to Acquire Foundation Medicine (FMI) for $137/Share, or $5.3B
Jun 19, 2018 01:00AM Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology
Jun 5, 2018 07:00AM Foundation Medicine to Present at Upcoming Investor Conferences
May 29, 2018 07:00AM Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care
May 24, 2018 07:05AM Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)
May 24, 2018 07:00AM Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck
May 21, 2018 07:03AM Foundation Medicine (FMI) Secures New ADLT Status for FoundationOne CDx
May 21, 2018 07:00AM Foundation Medicine Receives New ADLT Status for FoundationOne CDx™ from the Centers for Medicare and Medicaid Services (CMS)
May 2, 2018 04:01PM Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights
May 2, 2018 07:00AM Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer
Apr 26, 2018 06:00PM Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China
Apr 26, 2018 07:25AM Foundation Medicine (FMI) Says New Liquid Biopsy Assay Granted Breakthrough Device Designation
Apr 26, 2018 07:00AM Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration
Apr 17, 2018 07:00AM Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call
Apr 11, 2018 07:03AM Foundation Medicine (FMI), Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling
Apr 11, 2018 07:00AM Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies
Apr 9, 2018 08:54AM Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care
Mar 30, 2018 07:00AM Foundation Medicine Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagno
Mar 18, 2018 10:19PM Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx™ Across All Solid Tumo
Mar 16, 2018 02:00AM Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx™ in Japan
Mar 13, 2018 04:05PM Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit
Mar 8, 2018 06:30AM Foundation Medicine to Present at Cowen and Company’s 38th Annual Healthcare Conference
Mar 7, 2018 04:01PM Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook
Feb 13, 2018 06:30AM Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call
Feb 5, 2018 07:09AM Bristol-Myers Squibb (BMY) Reports Pivotal Phase 3 CheckMate-227 Study Provides Superior Progression-Free Survival (PFS) with the Opdivo Plus Yervoy Combination
Feb 5, 2018 06:59AM Pivotal Phase 3 CheckMate -227 Study Demonstrates Superior Progression-Free Survival (PFS) with the Opdivo Plus Yervoy Combination Versus Chemotherapy in First-Line Non-Small Cell Lung Cancer (NSCLC)
Jan 30, 2018 07:00AM Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clin
Jan 16, 2018 07:05AM Foundation Medicine (FMI), Pfizer (PFE) Announce Pact to Develop Companion Diagnostics for Pfizer's Oncology Portfolio
Jan 16, 2018 07:00AM Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer’s Oncology Portfolio
Jan 8, 2018 06:34AM Foundation Medicine (FMI) Prelim. Q4 Revenue Tops Views
Jan 8, 2018 06:30AM Foundation Medicine Reports Preliminary 2017 Results
Jan 3, 2018 04:01PM Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 6, 2017 07:00AM Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood
Nov 30, 2017 11:15PM FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics
Nov 1, 2017 04:01PM Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights
Oct 16, 2017 07:00AM Foundation Medicine to Present Validation for FoundationOne CDx™, a Comprehensive Genomic Profiling Assay for Advancing Precision Cancer Care
Oct 12, 2017 06:30AM Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call
Oct 10, 2017 05:00PM Foundation Medicine Appoints Tom Civik as Chief Commercial Officer
Oct 2, 2017 07:00AM Foundation Medicine Receives Approval from the State of New York for its FoundationACT Liquid Biopsy Assay
Sep 8, 2017 07:00AM Foundation Medicine to Present Validation Data for Its Assay Measuring Tumor Mutational Burden in Blood (bTMB), a New, Non-Invasive Predictor of Response to Immunotherapy
Aug 30, 2017 06:30AM Foundation Medicine to Present at the 2017 Wells Fargo Healthcare Conference
Aug 15, 2017 08:00AM Cancer Treatment Centers of America® and Foundation Medicine® Join Forces to Advance Precision Cancer Treatment
Aug 1, 2017 04:01PM Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
Jul 12, 2017 06:30AM Foundation Medicine Announces Timing for Second Quarter 2017 Financial Results and Conference Call
Jun 8, 2017 07:00AM ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR) Study
Jun 7, 2017 06:30AM Foundation Medicine to Identify Patients Eligible for National Cancer Institute’s NCI-MATCH (Molecular Analysis for Therapy Choice) Study
Jun 5, 2017 06:30AM Foundation Medicine to Present at Upcoming Investor Conferences
May 18, 2017 07:13AM Foundation Medicine (FMI) And Its Collaborators to Present New Data at ASCO
May 18, 2017 07:00AM Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling (CGP) in Personalized Clinical Care in Oncology
View More Recent Stories View Older Stories